NHI · XBRL financial data

National Health Investors financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (NHI's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue	80	79*	82	85	83	86*	89	91	90	106*	115	121
Revenue from contracts with customers	12	13*	13	13	14	14*	14	14	21	31*	37	45
General and administrative	4	5*	6	5	5	5*	7	6	6	8*	8	9
Total operating expenses	52	50*	51	52	55	54*	56	56	58	70*	78	87
Interest expense	15	15*	15	15	15	15*	14	15	14	14*	15	16
Income tax expense (benefit)	—	—	—	—	—	—	—	0	—	—	—	1
Net income (loss)	29	32*	31	35	29	43*	34	37	33	38*	40	56
Earnings per share, basic USD per share	0.68	0.74*	0.71	0.81	0.66	0.96*	0.75	0.79	0.69	0.80*	0.83	1.15
Earnings per share, diluted USD per share	0.68	0.74*	0.71	0.81	0.65	0.95*	0.74	0.79	0.69	0.80*	0.82	1.15
Weighted average shares, basic millions of shares	43	43*	43	43	43	45*	46	47	47	48*	48	48
Weighted average shares, diluted millions of shares	43	43*	43	44	44	45*	46	47	48	48*	49	48

Fiscal quarters (NHI's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	17	22	11	15	16	24	135	19	82	20	25	30
Property and equipment, net	2,120	2,107	2,093	2,106	2,097	2,211	2,270	2,316	2,303	2,474	2,555	2,566
Right-of-use asset	—	2	—	—	—	2	—	—	—	2	—	5
Total assets	2,499	2,488	2,478	2,477	2,460	2,614	2,783	2,696	2,690	2,797	2,890	2,964
Total liabilities	1,218	1,214	1,211	1,213	1,213	1,229	1,338	1,199	1,192	1,257	1,357	1,375
Retained earnings	2,435	2,467	2,498	2,533	2,562	2,605	2,639	2,676	2,709	2,747	2,787	2,843
Total stockholders' equity	1,260	1,254	1,248	1,244	1,229	1,366	1,426	1,480	1,481	1,522	1,515	1,571
Total liabilities and equity	2,499	2,488	2,478	2,477	2,460	2,614	2,783	2,696	2,690	2,797	2,890	2,964
Common shares outstanding (cover page) millions of shares	43	43	43	43	45	46	47	47	48	48	48	49

Fiscal quarters (NHI's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	29	32*	31	35	29	43*	34	37	33	38*	40	56
Net cash from operating activities	50*	53*	41	61*	49*	58*	46	60*	63*	68*	53	65*
Purchases of property and equipment	—	year only	—	—	—	year only	—	—	—	year only	—	—
Net cash from investing activities	(20)*	2*	(16)	(13)*	(2)*	(161)*	(75)	(48)*	42*	(187)*	(104)	(43)*
Proceeds from issuing common stock	—	year only	0	0*	0*	142*	65	58*	11*	47*	0	45*
Share repurchases	0*	0*	—	—	—	year only	—	—	—	—	—	—
Dividends paid	39*	39*	39	39*	39*	39*	41	42*	43*	44*	44	45*
Repayments of long-term debt	0*	50*	0	0*	75*	0*	0	76*	75*	50*	0	125*
Net cash from financing activities	(31)*	(49)*	(36)	(44)*	(46)*	112*	140	(129)*	(42)*	57*	56	4*
Net change in cash	(1)*	6*	(11)	4*	1*	9*	111	(118)*	62*	(62)*	5	25*

SIC 6798 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 6798 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
National Health Investors	30	121	65*	49.1M	Q2 FY26 10-QJun 30, 2026
Broadstone Net Lease	12	122	88*	192.0M	Q3 FY26 10-QSep 30, 2026
Dolby Laboratories	669	305	167*	not reported	Q3 FY26 10-QJun 26, 2026
Four Corners Property Trust	7.2	8	61*	109.8M	Q3 FY26 10-QSep 30, 2026
Lineage	58	1,361	311*	227.7M	Q2 FY26 10-QJun 30, 2026
OUTFRONT Media	31	523	108*	176.1M	Q2 FY26 10-QJun 30, 2026
EagleRock Land	62	42	not reported	not reported	Q2 FY26 10-QJun 30, 2026
Blackstone Mortgage Trust	512	not reported	(18)*	166.0M	Q3 FY26 10-QSep 30, 2026
Copt Defense Properties	24	197	91*	113.4M	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.